Skip to main content

Revance Therapeutics, Inc.

RVNCDelisted Feb 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001479290

Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in Revance Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
187
−25 vs. Q2 2023
Shares held
77.8M
−4.00M (−4.9%) vs. Q2 2023
Total value
$893.1M
−$1.18B (−56.9%) vs. Q2 2023
New holders
18
87 more added
Sold out
43
51 more reduced

3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 187 institutions
Q1 2021: 149 institutionsQ2 2021: 161 institutionsQ3 2021: 159 institutionsQ4 2021: 151 institutionsQ1 2022: 156 institutionsQ2 2022: 161 institutionsQ3 2022: 182 institutionsQ4 2022: 193 institutionsQ1 2023: 217 institutionsQ2 2023: 215 institutionsQ3 2023: 187 institutionsQ4 2023: 193 institutionsQ1 2024: 188 institutionsQ2 2024: 173 institutionsQ3 2024: 201 institutionsQ4 2024: 174 institutionsQ1 2025: 2 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $893.1M
Q1 2021: $1.53BQ2 2021: $1.60BQ3 2021: $1.53BQ4 2021: $864.7MQ1 2022: $1.06BQ2 2022: $774.3MQ3 2022: $1.82BQ4 2022: $1.36BQ1 2023: $2.46BQ2 2023: $2.07BQ3 2023: $893.1MQ4 2023: $636.4MQ1 2024: $409.4MQ2 2024: $209.3MQ3 2024: $429.9MQ4 2024: $249.2MQ1 2025: $425.0KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RVNC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20252$425.0K
Q4 2024174$249.2M
Q3 2024201$429.9M
Q2 2024173$209.3M
Q1 2024188$409.4M
Q4 2023193$636.4M
Q3 2023187$893.1M
Q2 2023215$2.07B
Q1 2023217$2.46B
Q4 2022193$1.36B
Q3 2022182$1.82B
Q2 2022161$774.3M
Q1 2022156$1.06B
Q4 2021151$864.7M
Q3 2021159$1.53B
Q2 2021161$1.60B
Q1 2021149$1.53B

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding RVNC in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Waypoint Capital Advisors, LLC0$00.00%−90,989−100.0%Sold out
State of New Jersey Common Pension Fund D0$00.00%−78,397−100.0%Sold out
Seven Eight Capital, LP0$00.00%−70,697−100.0%Sold out
Evolutionary Tree Capital Management, LLC0$00.00%−59,411−100.0%Sold out
Brookfield Asset Management Inc.0$00.00%−58,727−100.0%Sold out
Gilder Gagnon Howe & Co LLC0$00.00%−57,123−100.0%Sold out
Aigen Investment Management, LP0$00.00%−53,988−100.0%Sold out
Quantbot Technologies LP0$00.00%−51,118−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−44,001−100.0%Sold out
Squarepoint Ops LLC0$00.00%−32,206−100.0%Sold out
Jackson Creek Investment Advisors LLC0$00.00%−29,839−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−27,345−100.0%Sold out
Calamos Advisors LLC0$00.00%−24,923−100.0%Sold out
Neo Ivy Capital Management0$00.00%−23,952−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−23,100−100.0%Sold out
Wolverine Trading, LLC0$00.00%−19,346−100.0%Sold out
Janney Montgomery Scott LLC0$00.00%−16,010−100.0%Sold out
Virginia Retirement Systems Et Al0$00.00%−13,700−100.0%Sold out
AQR Capital Management LLC0$00.00%−13,483−100.0%Sold out
Keybank National Association0$00.00%−13,021−100.0%Sold out
Nebula Research & Development LLC0$00.00%−11,619−100.0%Sold out
GTS Securities LLC0$00.00%−11,024−100.0%Sold out
Parallax Volatility Advisers, L.P.0$00.00%−10,085−100.0%Sold out
New England Research & Management, Inc.0$00.00%−8,875−100.0%Sold out
NinePointTwo Capital0$00.00%−8,444−100.0%Sold out
Natixis0$00.00%−6,455−100.0%Sold out
West Tower Group, LLC0$00.00%−1,548−100.0%Sold out
Tilia Fiduciary Partners, Inc.0$00.00%−600−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−50−100.0%Sold out
Versant Capital Management, Inc0$00.00%−14−100.0%Sold out
PFS Investments Inc.––––Not filed
Pictet Asset Management SA––––Not filed
BerganKDV Wealth Management, LLC––––Not filed